GlassScriptPhysician profile
Joseph Hsin
NPI 1912951443
$32,989.73
in general payments reported to CMS, 2019-2025
21 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $646 · 2021: $15K · 2022: $13K · 2023: $595 · 2024: $2,318 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,347 · Travel and Lodging: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,347.14 |
| Travel and Lodging | $585.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qt Imaging, INC. | $25,439.88 | 2020-2022 | |
| Arthrex, INC. | $2,004.10 | 2019-2025 | |
| Gemini Mountain Medical, LLC | $1,583.45 | 2022-2025 | |
| Ossur Americas, INC. | $1,353.09 | 2024-2025 | Miami J, Unloader One X |
| Depuy Synthes Sales INC. | $668.05 | 2019-2025 | Fms, Healix Knotless Peek, Na |
| Horizon Therapeutics Plc | $629.19 | 2019-2022 | |
| Stryker Corporation | $386.71 | 2019-2025 | Crossflow, Aequalis Flex Revive |
| Smith+Nephew, INC. | $255.74 | 2019-2025 | Evos Mini, Evos, Aetos Shoulder System |
| Biotissue Holdings INC. | $207.11 | 2025 | |
| Davol INC. | $159.88 | 2023 | Arista Ah Flexitip |
| Vericel Corporation | $63.51 | 2022-2024 | Maci |
| Ferring Pharmaceuticals INC. | $58.14 | 2019-2023 | Euflexxa |
| Kci USA, INC. | $37.85 | 2022-2023 | Prevena |
| Zimmer Biomet Holdings, INC. | $28.26 | 2019 | |
| Molnlycke Health Care US, LLC | $18.73 | 2025 | Mepilex Border Post-Op |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $18.38 | 2020 | |
| Bioventus LLC | $18.25 | 2019 | |
| Fidia Pharma USA INC. | $15.36 | 2023 | Hymovis |
| Aesculap, INC. | $15.22 | 2024 | Elan 4 |
| Anika Therapeutics, INC. | $14.89 | 2022 | |
| Curonix LLC | $13.94 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,524,898.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hsin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.